Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beguin

Showing results (41-50 of 242) with videos related to

Pageof 25
Sort By:
Haematologica|September 21, 2004
CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancerFrédéric Baron, Sandra Copizza, Etienne Baudoux, et al.
Journal of Translational Medicine|May 22, 2016
Clinical-scale expansion of mesenchymal stromal cells: a large banking experienceChantal Lechanteur, Alexandra Briquet, Olivier Giet, et al.
World Journal of Gastroenterology|December 4, 2014
Rationale for the potential use of mesenchymal stromal cells in liver transplantationMorgan Vandermeulen, Céline Grégoire, Alexandra Briquet, et al.
Stem Cell Investigation|June 14, 2017
Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complicationsSophie Servais, Muriel Hannon, Régis Peffault de Latour, et al.
Haematologica|September 13, 2005
Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantationGaëtan Vanstraelen, Frédéric Baron, Pascale Frère, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Too-low iron doses and too many dropouts in negative iron trial?Matti Aapro, Yves Beguin, Gunnar Birgegård, et al.
American Journal of Hematology|July 26, 2021
Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplantMichelle Pirotte, Marianne Fillet, Laurence Seidel, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 10, 2018
Allogeneic mesenchymal stromal cells for refractory luminal Crohn's disease: A phase I-II studyCéline Gregoire, Alexandra Briquet, Caroline Pirenne, et al.
Haematologica|July 15, 2003
Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an updateFrédéric Baron, Pascale Frère, Etienne Baudoux, et al.
European Journal of Haematology|April 11, 2007
Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphomaChristophe Bonnet, Yves Beguin, Marie-France Fassotte, et al.
Pageof 25

Showing results (41-50 of 242) with videos related to

Sort By:
Pageof 25
Haematologica|September 21, 2004
CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancerFrédéric Baron, Sandra Copizza, Etienne Baudoux, et al.
Journal of Translational Medicine|May 22, 2016
Clinical-scale expansion of mesenchymal stromal cells: a large banking experienceChantal Lechanteur, Alexandra Briquet, Olivier Giet, et al.
World Journal of Gastroenterology|December 4, 2014
Rationale for the potential use of mesenchymal stromal cells in liver transplantationMorgan Vandermeulen, Céline Grégoire, Alexandra Briquet, et al.
Stem Cell Investigation|June 14, 2017
Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complicationsSophie Servais, Muriel Hannon, Régis Peffault de Latour, et al.
Haematologica|September 13, 2005
Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantationGaëtan Vanstraelen, Frédéric Baron, Pascale Frère, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Too-low iron doses and too many dropouts in negative iron trial?Matti Aapro, Yves Beguin, Gunnar Birgegård, et al.
American Journal of Hematology|July 26, 2021
Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplantMichelle Pirotte, Marianne Fillet, Laurence Seidel, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 10, 2018
Allogeneic mesenchymal stromal cells for refractory luminal Crohn's disease: A phase I-II studyCéline Gregoire, Alexandra Briquet, Caroline Pirenne, et al.
Haematologica|July 15, 2003
Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an updateFrédéric Baron, Pascale Frère, Etienne Baudoux, et al.
European Journal of Haematology|April 11, 2007
Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphomaChristophe Bonnet, Yves Beguin, Marie-France Fassotte, et al.
Pageof 25